Advantages of exosomal LRG1 include its high specificity to MM, non-invasive detection through liquid biopsy, and potential for targeted therapies to disrupt its tumor-promoting effects, offering new strategies for MM diagnosis and treatment 103. This evidence concerns the gene LRG1 and Miyoshi myopathy.